Skip to main content

Coronavirus clinical trials at UCSF

2 research studies open to eligible people

Showing trials for
  • COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)

    open to eligible females ages 13 years and up

    PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.

    San Francisco, California

  • Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease

    open to eligible people ages 18 years and up

    ORCHID is a multicenter, blinded, placebo-controlled, randomized clinical trial evaluating hydroxychloroquine for the treatment of adults hospitalized with COVID-19. Patients, treating clinicians, and study personnel will all be blinded to study group assignment.

    Fresno, California and other locations

Last updated: